School of Medicine
Showing 301-350 of 1,603 Results
-
Carol Clayberger
Professor (Research) of Pediatrics, Emerita
Current Research and Scholarly InterestsOur group uses molecular biology, biochemistry, and cellular immunology to investigate the activation and effector function of T lymphocytes. Research in the laboratory is currently focused on three areas: granulysin, a lytic molecule expressed late (7-12 days) after T cell activation; identification of correlates of immunity in diseases such as tuberculosis; and tolerance. The long term goal of this work is to develop new ways to treat human disease.
-
Harvey Cohen
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics, Emeritus
Current Research and Scholarly InterestsMy research interests extend from hypothesis-driven studies in biochemistry and cell biology to discovery-driven interests in proteomics and systems biology to clinical treatment of acute lymphoblastic leukemia of children, and pediatric palliative care.
-
Mitchell B Cohen
Elizabeth Wood Dunlevie Professor and Senior Associate Dean, Maternal and Child Health
BioMitchell B. Cohen, M.D., is a Professor in the Department of Pediatrics in the School of Medicine. He serves as the Chief Medical Officer for Stanford Medicine Children’s Health and the Senior Associate Dean in the School of Medicine for Maternal and Child Health. From 2014-2024, he was the Katharine Reynolds Ireland Chair of Pediatrics at the University of Alabama at Birmingham and the Physician-in-Chief of Children’s of Alabama. Prior to that, he served as the Director of Gastroenterology, Hepatology and Nutrition and Vice Chair of Pediatrics at Cincinnati Children’s Hospital Medical Center.
Dr. Cohen was the founding Director of the P30 Cincinnati Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Diseases His research focused on the mechanism of action of E. coli heat stable enterotoxin, a worldwide cause of infant diarrhea. His laboratory identified that increased guanylyl cyclase (GC-C) receptors for this toxin contributed to the increased susceptibility and severity of diarrhea seen in infants. Identification of the endogenous ligands for GC-C, guanylin and uroguanylin, led to development of knockout mice and an evolving understanding of intestinal secretion and pharmacologic treatment through this ligand-receptor family. Dr. Cohen had a long-standing NIH-supported program of vaccine trials for enteric infection, including a validated human cholera challenge model which resulted in licensure of a cholera vaccine.
Dr. Cohen has held leadership positions in several professional capacities. He served as the only pediatrician on the NIH Commission on Digestive Diseases; he was chair of the Section on Growth, Development and Nutrition of the American Gastroenterological Association (AGA) and the Section on Gastroenterology, Hepatology and Nutrition (SOGHN) of the American Academy of Pediatrics; he was President of NASPGHAN, the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Dr. Cohen was elected to membership in the Association of American Physicians and has received several lifetime achievement awards, including the Shwachman Award from NASPGHAN, the Saul Horowitz Jr. Award from Mt. Sinai, and the UAB Department of Pediatrics Lifetime Achievement Award. -
Pasqualina Colella
Affiliate, Pediatrics - Genetics
BioDr. Pasqualina Colella is a scientist with expertise in gene and cell therapy for inherited diseases. She is currently a Senior Research Scientist at Stanford University, where she leads translational research on hematopoietic stem cell transplantation (HSCT), microglia replacement, myeloid cell recruitment to the central nervous system, and genome editing. Her goal is to improve treatment outcomes for neurodegenerative lysosomal storage diseases.
Dr. Colella earned her PhD at TIGEM (Italy), where she developed gene therapies for inherited retinal disorders, including dual AAV approaches for large gene delivery targeting Usher syndrome type 1B and Stargardt disease. During her postdoctoral studies at Genethon (France), she advanced AAV-based gene therapy for Pompe disease, improving efficacy through transgene and promoter engineering. Her work has contributed to several ongoing clinical trials, including those for USH1B and Pompe disease.
Her research has led to more than 30 peer-reviewed publications (16 as first author, 7 as co-corresponding) and 6 patents. She has received awards including the Marie Skłodowska-Curie Fellowship, the Innovative Research Grant from the National MPS Society, and Stanford School of Medicine Shoshana Levy Award to Support Women in Science (Career Development Award). She was also a finalist for the ERC Starting Grant in 2019. -
Ruben J Colman, MD, PhD
Assistant Professor of Pediatrics (Gastroenterology)
BioDr. Colman is a pediatric gastroenterologist and physician-scientist with an overarching goal to improve and optimize the quality of care and outcomes for children with inflammatory bowel diseases (IBD) through precision medicine approaches. His interdisciplinary team science research program focuses on making precision medicine clinically actionable through innovative solutions merging clinical pharmacology knowledge with ‘-omics’ discoveries using microbiome and metabolomics signatures. Part of this work includes translating these findings into improved clinical treat-to-target endpoints with immediate noninvasive point-of-care measures such as intestinal ultrasound.
The foundation of his current work originates from his PhD titled ‘Precision Dosing and Personalized Medicine in pediatric IBD’. During his training, Dr. Colman was also an American Gastroenterological Association (AGA) editorial fellow for Gastroenterology and he is actively involved in the committees of several professional societies including the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), the Crohn’s and Colitis Foundation and the International Bowel UltraSound (IBUS) Group. Dr. Colman is supported by a Career Development K23 Award from the NIH, which focuses on evaluating personalized treatment strategies for children with Crohn's disease, specifically examining microbial and transmural intestinal ultrasound findings. He is also funded by awards of the NASPGHAN Foundation and the Stanford Pediatrics Physician-Scientist Bridge to K Program. -
Le Cong
Associate Professor of Pathology (Pathology Research) and of Genetics
Current Research and Scholarly InterestsOur lab develops gene-editing technologies like novel CRISPR systems and large gene insertion techniques for gene and cell therapy. We also leverage these gene-editing tools for single-cell functional screening to probe mechanisms of cancer, immunological, and aging-associated diseases. To accelerate our work, we integrate AI and machine learning to design and evolve therapeutic RNAs/proteins, and build AI-XR co-scientists like LabOS that bridge AI computation and biomedical experimentation.
-
Christopher H. Contag
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsWe develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.
-
David N. Cornfield
Anne T. and Robert M. Bass Professor of Pediatric Pulmonary Medicine
Current Research and Scholarly InterestsOver the past 20 years, the Cornfield Laboratory has focused upon basic, translational and clinical research, with a primary focus on lung biology. As an active clinician-scientist, delivering care to acutely and chronically ill infants and children, our lab focuses on significant clinical challenges and tried to use science to craft novel solutions to difficult clinical problems.
-
Jennifer Cory
Director of Strategy and Operations, Peds/CDCM Center for Definitive and Curative Medicine
Current Role at StanfordDirector of Strategy and Operations, Center for Definitive and Curative Medicine
-
Tina Cowan
Professor of Pathology (Clinical) and, by courtesy, of Pediatrics (Genetics)
Current Research and Scholarly Interestsscreening and diagnosis of patients with inborn errors of metabolism, including newborn screening, development of new testing methods and genotype/phenotype correlations.
-
Kenneth L. Cox
Professor of Pediatrics (Gastroenterology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsGastroenterology, biliary motility, hormonal regulation, embryology, gastrointestinal tract, clinical management of pediatric liver transplant recipients.
-
Justin Crest
Associate Director of Team Science, Pediatrics
BioJustin is an experienced research scientist who has a passion for collaborative team science. He has recieved support from NIH, W.M. Keck, and the Damon Runyon Cancer Research Foundation for his multidisceplenary projects. At Stanford, he facilitates faculty and trainees to strategically position their grants and research goals in order to maximize funding success, while also encouraging new collaborative research within Pediatrics and campus-wide.
-
Agnieszka Czechowicz, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsDr. Czechowicz’s research is aimed at understanding how hematopoietic stem cells interact with their microenvironment in order to subsequently modulate these interactions to improve bone marrow transplantation and unlock biological secrets that further enable regenerative medicine broadly. This work can be applied across a variety of disease states ranging from rare genetic diseases, autoimmune diseases, solid organ transplantation, microbiome-augmentation and cancer.
-
Genevieve D'Souza
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
BioGenevieve D’souza MD, FASA is a Clinical Professor in the Pediatric Anesthesia division of the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University. She is a Board-certified Pediatric Anesthesiologist , Fellowship trained Pediatric Pain Doctor, and trained in Medical Acupuncture.
She is a practicing Chronic Pediatric Pain Doctor at Stanford Medicine Children's Health and is also part of the Acute Pain Service. She is the Clinical Director of the Pediatric Pain Division. She is also the Director of the Pediatric Anesthesia Resource Center at Lucile Packard Children’s Hospital.
She is also the Senior Editor for the Visual Pearl Series For the Society of Pediatric Pain Medicine and on the Board of Directors for Society of Pediatric Pain Medicine. -
Gary Dahl
Professor of Pediatrics (Hematology/Oncology), Emeritus
Current Research and Scholarly InterestsHematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
-
Jeremy Dahl
Professor of Radiology (Pediatric Radiology)
Current Research and Scholarly InterestsMy current research encompasses ultrasonic beamforming and image reconstruction methods, with application areas in improving ultrasound image quality in difficult-to-image patients and ultrasound molecular imaging of cancer. My lab also employs beamforming concepts to enhance other areas of ultrasound research.
-
Kate Dahl, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Clinical Associate Professor (By courtesy), Pediatrics - NephrologyBioDr. Kate Dahl specializes in working with children and families who are affected by medical illness. She has practiced at Stanford since 2014 and is the primary pediatric psychologist for the kidney transplant team. She also serves as the Director of the Medical Coping and Wellness Clinic in Child Psychiatry. Her work focuses on adjustment to new diagnosis, coping with illness and treatment, and adherence to the medical regimen. Dr. Dahl is particularly interested in the experience of adolescents with chronic medical conditions and leads groups for teens who have received kidney transplants.
-
Heike Daldrup-Link
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsAs a physician-scientist involved in the care of pediatric patients and developing novel pediatric molecular imaging technologies, my goal is to link the fields of nanotechnology and medical imaging towards more efficient diagnoses and image-guided therapies. Our research team develops novel imaging techniques for improved cancer diagnosis, for image-guided-drug delivery and for in vivo monitoring of cell therapies in children and young adults.
-
Rebecca Dang
Instructor, Peds/Hospital Medicine
BioDr. Rebecca Dang is an Instructor in the Division of General Pediatrics at Stanford University. She earned her medical degree at Georgetown School of Medicine and completed her pediatric residency at Kaiser Permanente Northern California. She also completed pediatric hospital medicine fellowship and a master’s program in clinical research and epidemiology at Stanford University. Dr. Dang provides clinical care for children on the pediatric ward and newborn nursery.
Dr. Dang’s research interest focuses on high-value pediatric care, which she hopes to improve through building evidence for common, understudied practices. Common practices that are ubiquitous throughout pediatric medicine are temperature measurement and management. Despite temperature measurement and the subsequent detection of ‘normal’ or ‘abnormal’ values driving clinical decision making, these temperature thresholds may be outdated or poorly defined. Dr. Dang has led many projects on temperature-related topics, including routine temperature measurement at well-child visits, pediatric temperature percentiles, risk factors for and outcomes of neonatal hypothermia in the newborn nursery, and newborn temperature norms. This work has led to first-author publications in the high-impact journals of Academic Pediatrics, Pediatrics, Journal of Pediatrics, JAMA Network Open, and Hospital Pediatrics. She has secured continual institutional and foundation funding, including a Maternal & Child Health Research Institute clinical trainee award and master’s tuition program, Gerber Foundation main and novice research award, the Department of Pediatrics’ Bridge-to-K Program, and the PEDSnet Scholars Program. -
Leonardo Daniels
Casual Employee, Pediatrics - General Pediatrics
FOH Associate, Stanford LiveBioLeonardo is currently working in the Oncology/Hematology Department as an Undergraduate Researcher and working in Education where he is making a better tomorrow.
-
Gary Darmstadt
Sue Alvarez Professor of Neonatal and Developmental Medicine and Professor (Teaching), by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsI have extensive experience in the development of global health innovations and in working to test and scale-up health interventions. At Stanford University, I am playing a leading role in developing global women and children’s health research and educational programs, including the establishment of a Global Center for Gender Equality at Stanford University. My research focuses on advancing child health and development in low resource settings and advancing gender equality and health globally, and includes several applications of artificial intelligence. Before joining Stanford, I was Senior Fellow at the Bill & Melinda Gates Foundation (BMGF), where I led the development of initiatives to address gender inequalities and empower women and girls. Prior to this role, I served as the BMGF Director of Family Health, leading strategy development and implementation across maternal, newborn and child health, nutrition, and family planning. In this role, I was responsible for investments ranging from scientific discovery to intervention development and delivery of interventions at scale. I worked closely with the Discovery team to shape discovery and development investments and was a co-founder of the Saving Lives at Birth Development Grand Challenge, the Putting Women and Girls at the Center of Development Grand Challenge, and the Healthy Birth, Growth and Development initiative. Based on these experiences, I understand how to identify knowledge gaps and generate evidence of impact for new interventions, and how to utilize evidence to influence the policy dialogue leading to programmatic adoption and scale-up of interventions in low income settings. As Director of Family Health, I also co-led the development and implementation of the BMGF global health strategy for India, which cuts across multiple health and development sectors. Before joining BMGF, I was Associate Professor and Founding Director of the International Center for Advancing Neonatal Health in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. I led the development of newborn health research, including numerous facility- and community-based maternal and child health research trials. Before joining Johns Hopkins, I was Senior Research Advisor for the $50M Saving Newborn Lives program of Save the Children-US, where I led the development and implementation of the global research strategy for newborn health and survival.
-
Reedhi Dasani
Academic Prog Prof 2, Pediatrics - Neonatology
Current Role at StanfordPoint-of-Care Ultrasound (POCUS) Program Manager
-
Sujal Dave
Postdoctoral Scholar, Cardiology
BioSujal Dave, PhD, is a Postdoctoral Scholar in the Cardiovascular Biomechanics Computation Lab at Stanford University.
He recently completed his Ph.D. in Mechanical Engineering at the University of Calgary under the supervision of Dr. Artem Korobenko, where he developed consistent reduced order modeling frameworks for turbulent flows using variational multiscale methods and stabilized finite elements. His doctoral research advanced large-scale wind turbine wake simulations with applications to renewable energy and environmental flows. -
Kara Davis
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsChildhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
